{
    "2018-03-07": [
        [
            {
                "time": "2018-03-01",
                "original_text": "Pharmaceutical Industry Outlook - March 2018",
                "features": {
                    "keywords": [
                        "Pharmaceutical",
                        "Industry",
                        "Outlook"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-01-31",
                "original_text": "Analyzing Gilead Sciences’ Other Products in 4Q17",
                "features": {
                    "keywords": [
                        "Gilead",
                        "Sciences",
                        "Products",
                        "4Q17"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-01-31",
                "original_text": "Johnson & Johnson’s Consumer Segment in 4Q17",
                "features": {
                    "keywords": [
                        "Johnson",
                        "Johnson",
                        "Consumer",
                        "Segment",
                        "4Q17"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-31",
                "original_text": "How Bristol-Myers Squibb’s Sprycel and Empliciti Performed in 4Q17",
                "features": {
                    "keywords": [
                        "Bristol-Myers",
                        "Squibb",
                        "Sprycel",
                        "Empliciti",
                        "4Q17"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "The Swiss Stock Market Finished Higher After Late Recovery",
                "features": {
                    "keywords": [
                        "Swiss",
                        "Stock",
                        "Market",
                        "Finished",
                        "Higher",
                        "Late",
                        "Recovery"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "finance"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-01",
                "original_text": "Novartis, U.S. partner plan remote trials to boost participation",
                "features": {
                    "keywords": [
                        "Novartis",
                        "U.S.",
                        "partner",
                        "remote",
                        "trials",
                        "boost",
                        "participation"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-01-01",
                "original_text": "Novartis, Science 37 Commit To Launch Up To 10 Trials Over Three Years",
                "features": {
                    "keywords": [
                        "Novartis",
                        "Science",
                        "37",
                        "Commit",
                        "Launch",
                        "Trials",
                        "Three",
                        "Years"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}